Net profit of Jubilant Pharmova rose 51.05% to Rs 100.90 crore in the quarter ended December 2024 as against Rs 66.80 crore during the previous quarter ended December 2023. Sales rose 8.92% to Rs 1813.70 crore in the quarter ended December 2024 as against Rs 1665.20 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 1813.70 | 1665.20 | 9 |
| OPM % | 15.83 | 13.09 | - |
| PBDT | 240.70 | 195.60 | 23 |
| PBT | 149.40 | 101.00 | 48 |
| NP | 100.90 | 66.80 | 51 |
Powered by Capital Market - Live News